EP Patent

EP4499607A1 — Novel ionizable lipids and lipid nanoparticles and methods of using the same

Assigned to Sail Biomedicines Inc · Expires 2025-02-05 · 1y expired

What this patent protects

The disclosure relates to novel ionizable lipids and lipid compositions and pharmaceutical compositions comprising these ionizable lipids that can be used in the delivery of therapeutic agent.

USPTO Abstract

The disclosure relates to novel ionizable lipids and lipid compositions and pharmaceutical compositions comprising these ionizable lipids that can be used in the delivery of therapeutic agent.

Drugs covered by this patent

Patent Metadata

Patent number
EP4499607A1
Jurisdiction
EP
Classification
—
Expires
2025-02-05
Drug substance claim
No
Drug product claim
No
Assignee
Sail Biomedicines Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.